MEP amplitude showed a trend to an increase in PD patients with the wild-type genotype compared to healthy controls in T0 and T2 (Fig. 8 ).
← all excerpts
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
1
—
—